FDA
-
-
-
-
-
-
-
Lifeward raises $5.6M in convertible notes with $5.6M more tied to milestones
-
-
-
-
-
-
-
Lifeward to Report First Quarter 2026 Financial Results on May 15, 2026
-
-
-
-
-
-
-
Lifeward regains NASDAQ minimum bid price compliance
-
-
-
-
-
-
-
Lifeward’s ReWalk™ Personal Exoskeleton Now Covered by Aetna, Coverage Expands to Include Three of the Largest Medicare Advantage Insurers
-
-
-
-
-
-
-
Lifeward expands ReWalk exoskeleton distribution to Mexico, Thailand, UAE
-
-
-
-
-
-
-
Lifeward Achieves CE Mark Approval for the ReWalk 7 Personal Exoskeleton
-
-
-
-
-
-
-
Administrative Law Judge Determines ReWalk Personal Exoskeleton is “Reasonable and Necessary” for Medicare Beneficiary
-
331,289 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

